Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company XBiotech Inc.
Description mAb against Staphylococcus aureus based on True Human technology
Molecular Target Not applicable
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I/II
Standard IndicationStaphylococcus
Indication DetailsTreat Staphylococcus aureus infection
Regulatory Designation U.S. - Fast Track (Treat Staphylococcus aureus infection)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today